Dn B Asset Management As Exact Sciences Corp Transaction History

Dn B Asset Management As

$19.9 Billion
Q2 2024

A detailed history of Dn B Asset Management As transactions in Exact Sciences Corp stock. As of the latest transaction made, Dn B Asset Management As holds 239,883 shares of EXAS stock, worth $15.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

239,883

Previous 163,036 47.13%

Holding current value

$15.7 Million

Previous $11.3 Million 9.98%

% of portfolio

0.05%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 05, 2024	BUY	$41.33 - $74.26 $3.18 Million - $5.71 Million	76,847 Added 47.13%	239,883 $10.1 Million
Q1 2024 Apr 12, 2024	BUY	$56.27 - $73.77 $1.05 Million - $1.37 Million	18,618 Added 12.89%	163,036 $11.3 Million
Q4 2023 Jan 04, 2024	SELL	$59.06 - $75.72 $163,182 - $209,214	-2,763 Reduced 1.88%	144,418 $10.7 Million
Q3 2023 Oct 13, 2023	BUY	$65.94 - $99.04 $3.04 Million - $4.57 Million	46,153 Added 45.68%	147,181 $10 Million
Q2 2023 Jul 06, 2023	SELL	$62.68 - $95.05 $1.19 Million - $1.81 Million	-19,059 Reduced 15.87%	101,028 $9.49 Million
Q1 2023 Apr 20, 2023	SELL	$47.19 - $70.77 $1.43 Million - $2.15 Million	-30,312 Reduced 20.15%	120,087 $8.14 Million
Q4 2022 Jan 12, 2023	SELL	$30.35 - $53.15 $3.06 Million - $5.35 Million	-100,683 Reduced 40.1%	150,399 $7.45 Billion
Q3 2022 Oct 11, 2022	BUY	$31.97 - $49.37 $2.55 Million - $3.94 Million	79,858 Added 46.64%	251,082 $8.16 Million
Q2 2022 Jul 08, 2022	BUY	$35.61 - $76.23 $352,396 - $754,372	9,896 Added 6.13%	171,224 $6.74 Billion
Q1 2022 Apr 08, 2022	BUY	$57.56 - $82.54 $326,768 - $468,579	5,677 Added 3.65%	161,328 $11.3 Million
Q4 2021 Jan 12, 2022	BUY	$72.5 - $100.68 $1.69 Million - $2.35 Million	23,318 Added 17.62%	155,651 $12.1 Million
Q3 2021 Oct 15, 2021	BUY	$90.24 - $124.05 $3.39 Million - $4.66 Million	37,578 Added 39.66%	132,333 $12.6 Million
Q2 2021 Jul 06, 2021	BUY	$93.66 - $139.27 $5.83 Million - $8.68 Million	62,294 Added 191.9%	94,755 $11.8 Billion
Q1 2021 Apr 15, 2021	BUY	$116.57 - $155.01 $1.63 Million - $2.17 Million	14,013 Added 75.96%	32,461 $4.28 Million
Q4 2020 Jan 19, 2021	BUY	$99.61 - $142.12 $160,670 - $229,239	1,613 Added 9.58%	18,448 $2.44 Million
Q3 2020 Oct 14, 2020	BUY	$72.92 - $102.01 $96,108 - $134,449	1,318 Added 8.49%	16,835 $1.72 Million
Q2 2020 Jul 08, 2020	BUY	$55.75 - $92.75 $88,363 - $147,008	1,585 Added 11.38%	15,517 $1.35 Billion
Q1 2020 Apr 17, 2020	SELL	$37.9 - $104.44 $94,787 - $261,204	-2,501 Reduced 15.22%	13,932 $808,000
Q4 2019 Jan 13, 2020	BUY	$77.66 - $99.74 $234,921 - $301,713	3,025 Added 22.56%	16,433 $1.52 Million
Q3 2019 Oct 16, 2019	BUY	$90.37 - $122.49 $59,644 - $80,843	660 Added 5.18%	13,408 $1.21 Million
Q2 2019 Jul 08, 2019	BUY	$89.51 - $118.04 $1.14 Million - $1.5 Million	12,748 New	12,748 $0

Others Institutions Holding EXAS

# of Institutions

610

Shares Held

166M

Call Options Held

1.93M

Put Options Held

1.23M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $11.6B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.

Account

Dn B Asset Management As Exact Sciences Corp Transaction History